SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Teva Pharmaceutical Indus Q1 Adj. EPS $0.760 Beats $0.590 Estimate, Sales $4.400B Beat $4.150B Estimate

Teva Pharmaceutical Indus (NYSE:TEVA) reported quarterly earnings of $0.760 per share which beat the analyst consensus estimate of $0.590 by 28.81 percent. This is a 26.67 percent increase over earnings of $0.600 per

Benzinga · 05/07/2020 11:00

Teva Pharmaceutical Indus (NYSE:TEVA) reported quarterly earnings of $0.760 per share which beat the analyst consensus estimate of $0.590 by 28.81 percent. This is a 26.67 percent increase over earnings of $0.600 per share from the same period last year. The company reported quarterly sales of $4.400 billion which beat the analyst consensus estimate of $4.150 billion by 6.02 percent. This is a 2.44 percent increase over sales of $4.295 billion the same period last year.